Florida Medication Safety Initiative (FMSI)FMQAI will assemble and assist local community teams with participation in the national Patient Safety and Clinical Pharmacy Services Collaborative (PSPC). The goal of QIO-supported PSPC participation is to coordinate clinical pharmacy services across medical practices, health plans, hospitals, and other stakeholders in activities to reduce Adverse Drug Events (ADEs). Adverse drug events (ADEs) disproportionately affect patients over the age of 65.
FMQAI will contribute to the PSPC teams through consistent application of quality improvement efforts to reduce and prevent adverse drug events. QIO supported teams will target Medicare, Medicare Advantage and dual eligible patients that are considered “high risk” for adverse drug events.
Interventions will incorporate evidence-based practices from the national PSPC. The Florida PSPC ADEs project will be part of the national PSPC, drawing on the knowledge of national and local leaders in medication safety.
Teams will receive support through face-to-face and virtual meetings, as well as an assortment of collaboration and learning tools via the Healthcare Communities knowledge-sharing portal. Each team will recruit 50-100 eligible beneficiaries and monitor ADEs, pADEs, HbA1c levels, and other clinical measures.
Between August 2011 and July 2014, FMQAI will work with seven to eight community teams, synchronizing activities with the national PSPC. Recruitment for this initiative is ongoing.
If your organization is interested in participating with FMQAI in this exciting initiative please contact Sophia Cherry, Rph. Quality Specialist.